跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,516 条关于
“Neuroendocrine carcinoma”
全部
20,516
临床试验
18,356
药物
103
机构
2
资讯
2,055
2年前
ABD-147 and PT217 Receive FDA Orphan Drug Designations for Neuroendocrine Carcinoma Treatment
去年
LBL-024 Bispecific Antibody Shows 75% Response Rate in Advanced Neuroendocrine Carcinoma Trial
去年
Leads Biolabs' LBL-024 Receives FDA Orphan Drug Designation for Neuroendocrine Cancer
去年
Combination Therapy Achieves 15-Month Progression-Free Survival in Advanced Large-Cell Neuroendocrine Lung Carcinoma
去年
Abdera Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
去年
BI 764532 T-Cell Engager Shows Promise in DLL3-Positive Neuroendocrine Carcinomas with 29% Response Rate
去年
Phase 1 Trial Explores Oncolytic Virus SVV-001 with Nivolumab and Ipilimumab in Neuroendocrine Neoplasms
去年
ESMO 2025 to Showcase Breakthrough Immunotherapy Trials in Head and Neck and Endocrine Cancers
去年
FDA Grants Fast Track Designation to Phanes Therapeutics' PT217 for Neuroendocrine Prostate Cancer
去年
Leads Biolabs' LBL-024 Receives FDA Orphan Drug Designation for Neuroendocrine Cancer
第 1 页,共 206 页
上一页
下一页